Afirma Xpression Atlas (XA) Variant and Fusion Search
Afirma XA results are categorized by level of clinical validation.
Enter a Gene + Variant combination or Fusion Pair to view validated clinical literature.
Afirma XA:
Informs selection of surgical and therapeutic decisions for Afirma GSC Suspicious, Bethesda V, and Bethesda VI nodules1
Is clinically validated1 and informed by The Cancer Genome Atlas (TCGA),2 extensive published literature, and Veracyte R&D discovery using nearly 40,000 samples3
Is the largest thyroid gene and fusion panel available, comprised of 593 genes, 905 variants, and 235 fusion pairs3
Veracyte® portal
This portal makes it easy to receive, manage, and search electronic patient reports
If you would like access to the Veracyte Portal, please download, complete, and fax or email your completed New User Request Form to Veracyte client services at 650.243.6388 or
support@veracyte.com..
